Raphael Pharmaceutical Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$44.00K, a 241.94% decline year-over-year.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $31.00K, a 45.61% decline year-over-year.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $57.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $26.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$211.00K.
- Raphael Pharmaceutical Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$58.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$44.00K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$44.00K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $26.00K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$16.00K 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $31.00K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$211.00K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$190.00K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | -$110.00K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $57.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$58.00K 10-K · filed 2025-03-31 |